Announcements Trials
Browse Landscape

Phase

Phase 2 171Phase 1 110Phase 1/2 47Phase 3 45Phase NA 9Phase 4 4Phase 2/3 3Phase EARLY_PHASE1 2

Status

Unknown 6Completed 4Terminated 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 4Liver Neoplasms 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Cisplatin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Completed × Sorafenib × Clear all
NCT02961998 2019-09-10

Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail

Sun Yat-sen University

Phase 4 Completed
116 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01409499 2018-09-11

2011PTAHCC

Sun Yat-sen University

Phase 4 Completed
180 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT01203787 2015-03-05

Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)

University of Florida

Phase 4 Completed
120 enrolled 14 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01098760 2013-10-31

HATT

Bayer

Phase 4 Completed
151 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡